Averywell
PrivateLast Round
Pre Seed
Apr 27, 2024
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Averywell is a med-tech company that develops a non-invasive, miRNA-based liquid biopsy technology for early lung cancer detection and management.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical AI, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Usage-Based SaaS, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Averywell Comparables
Compare Averywell with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Oxford Cancer Analytics | 83% | |
| Hummingbird Diagnostics GmbH | 81% | |
| Biomark Diagnostics Inc. | 77% | |
Averywell Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Pre Seed | Apr 27, 2024 |
Averywell Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Barclays Eagle Labs | Accelerator |
| Genesis Ventures | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 16, 2026
Monthly visitors grew 270% MoM, from 319 to 1.2K.
- Feb 17, 2026
Grew 150% QoQ, from 2 to 5 employees.
Averywell Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Averywell's valuation, stock price, and market status.